| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; YU-JEN FANG; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-M.; YU-JEN FANG; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; YU-JEN FANG; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; YU-JEN FANG; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; YU-JEN FANG; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; YU-JEN FANG; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; YU-JEN FANG; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
YU-JEN FANG; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; YU-JEN FANG; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
Han M.-L.; Lee Y.-C.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors
|
YU-JEN FANG; Cheng T.-Y.; Sun M.-S.; Yang C.-S.; Chen J.-H.; Liao W.-C.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
Yang S.-H.; Lin L.-W.; YU-JEN FANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Barium appendicitis
|
YU-JEN FANG; Wang H.-P.; Ho C.-M.; Liu K.-L. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
A rare diagnosis of right upper quadrant abdominal pain
|
Chung C.-S.; Wang H.-P.; YU-JEN FANG; Hu R.-H.; Hsiao J.-K.; Chen C.-G.H. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:43:07Z |
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|
El Bairi, Khalid; Haynes, Harry R; Blackley, Elizabeth; Fineberg, Susan; Shear, Jeffrey; Turner, Sophia; de Freitas, Juliana Ribeiro; Sur, Daniel; Amendola, Luis Claudio; Gharib, Masoumeh; Kallala, Amine; Arun, Indu; Azmoudeh-Ardalan, Farid; Fujimoto, Luciana; Sua, Luz F; Liu, Shi-Wei; HUANG-CHUN LIEN; Kirtani, Pawan; Balancin, Marcelo; El Attar, Hicham; Guleria, Prerna; Yang, Wenxian; Shash, Emad; Chen, I-Chun; Bautista, Veronica; Do Prado Moura, Jose Fernando; Rapoport, Bernardo L; Castaneda, Carlos; Spengler, Eunice; Acosta-Haab, Gabriela; Frahm, Isabel; Sanchez, Joselyn; Castillo, Miluska; Bouchmaa, Najat; Md Zin, Reena R; Shui, Ruohong; Onyuma, Timothy; Yang, Wentao; Husain, Zaheed; Willard-Gallo, Karen; Coosemans, An; Perez, Edith A; Provenzano, Elena; Ericsson, Paula Gonzalez; Richardet, Eduardo; Mehrotra, Ravi; Sarancone, Sandra; Ehinger, Anna; Rimm, David L; Bartlett, John M S; Viale, Giuseppe; Denkert, Carsten; Hida, Akira I; Sotiriou, Christos; Loibl, Sibylle; Hewitt, Stephen M; Badve, Sunil; Symmans, William Fraser; Kim, Rim S; Pruneri, Giancarlo; Goel, Shom; Francis, Prudence A; Inurrigarro, Gloria; Yamaguchi, Rin; Garcia-Rivello, Hernan; Horlings, Hugo; Afqir, Said; Salgado, Roberto; Adams, Sylvia; Kok, Marleen; Dieci, Maria Vittoria; Michiels, Stefan; Demaria, Sandra; Loi, Sherene |
| 臺大學術典藏 |
2022-02-14T07:10:32Z |
Association between the total plasma isomers of per- and polyfluoroalkyl substances and erythrograms in young and middle-aged Taiwanese populations
|
Lin C.-Y.; Lee H.-L.; Wang C.; Sung F.-C.; TA-CHEN SU |
| 臺大學術典藏 |
2022-02-14T07:10:32Z |
Relationship between life-time exposure to ambient fine particulate matter and carotid artery intima-media thickness in Australian children aged 11–12 years
|
Guo Y.L.; Ampon R.D.; Hanigan I.C.; Knibbs L.D.; Geromboux C.; TA-CHEN SU; Negishi K.; Poulos L.; Morgan G.G.; Marks G.B.; Jalaludin B. |
| 臺大學術典藏 |
2022-02-14T07:10:32Z |
Seasonal effects of high-altitude forest travel on cardiovascular function: An overlooked cardiovascular risk of forest activity
|
Tsao T.-M.; Hwang J.-S.; Tsai M.-J.; Lin S.-T.; Wu C.; TA-CHEN SU |
| 臺大學術典藏 |
2022-02-14T07:10:33Z |
Clean air, smart cities, healthy hearts: Action on air pollution for cardiovascular health
|
Brauer M.; Davaakhuu N.; Nuñez M.C.E.; Hadley M.; Kass D.; Miller M.; Prabhakaran D.; Sliwa K.; TA-CHEN SU; Vaartjes I.C.H.; Vedanthan R.; Mwangi J.; Armstrong-Walenczak K. |
| 臺大學術典藏 |
2022-02-14T07:10:33Z |
Positive association between endothelium–platelet microparticles and urinary concentration of lead and cadmium in adolescents and young adults
|
Lee C.-K.; Wu C.; Lin C.-Y.; Huang P.-C.; Sung F.-C.; TA-CHEN SU |
| 臺大學術典藏 |
2022-02-14T07:10:33Z |
Investigating early progression of Hodgkin lymphoma in a two-center analysis
|
Yu T.-C.; SHAN-CHI YU; Wang R.-C.; Lai S.-F.; Teng C.-L.J.; Lin J.-W.; Lin W.-L.; Huang T.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:33Z |
Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission
|
Chen C.-Y.; Chen P.-H.; Chen J.-K.; TA-CHEN SU |
| 臺大學術典藏 |
2022-02-14T07:10:34Z |
A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus
|
SHAN-CHI YU; Ko K.-Y.; Teng S.-C.; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L. |
| 臺大學術典藏 |
2022-02-14T07:10:34Z |
Morphologic Spectrum of Lymphadenopathy in Adult-onset Immunodeficiency (Anti-interferon-γ Autoantibodies)
|
Thingujam B.; Syue L.-S.; Wang R.-C.; Chen C.-J.; SHAN-CHI YU; Chen C.-C.; Medeiros L.J.; Liao I.-C.; Tsai J.-W.; Chang K.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:34Z |
Distinguishing lupus lymphadenitis from Kikuchi disease based on clinicopathological features and C4d immunohistochemistry
|
SHAN-CHI YU; Chang K.-C.; Wang H.; Li M.-F.; Yang T.-L.; Chen C.-N.; Chen C.-J.; Chen K.-C.; Shen C.-Y.; Kuo P.-Y.; Lin L.-W.; Lin Y.-M.; Lin W.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:35Z |
LncRNA MALAT1 facilitates ovarian cancer progression through promoting chemoresistance and invasiveness in the tumor microenvironment
|
TSUI-LIEN MAO; Fan M.-H.; Dlamini N.; Liu C.-L. |
| 臺大學術典藏 |
2022-02-14T07:10:35Z |
The molecular landscape influencing prognoses of epithelial ovarian cancer
|
Liu C.-L.; Yuan R.-H.; TSUI-LIEN MAO |
| 臺大學術典藏 |
2022-02-14T07:10:35Z |
Rare clinical manifestations of primary peritoneal serous carcinoma presenting as colorectal cancer: A report of two cases
|
Kao T.-C.; TSUI-LIEN MAO; Cheng C.-Y.; Chen I.-H.; Cheng W.-F. |
| 臺大學術典藏 |
2022-02-14T07:10:36Z |
Malignant gastrointestinal neuroectodermal tumor in head and neck: two challenging cases with diverse morphology and different considerations for differential diagnosis
|
Kuo C.-T.; Kao Y.-C.; Huang H.-Y.; Hsiao C.-H.; JEN-CHIEH LEE |
| 臺大學術典藏 |
2022-02-14T07:10:36Z |
Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions
|
Lee P.-H.; Kao Y.-C.; Hsieh T.-H.; Liao J.-B.; Li C.-F.; JEN-CHIEH LEE; Chang Y.-M.; Chang C.-D.; Huang S.-C.; Chen T.-J.; Liu T.-T.; Yu S.-C.; Huang H.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:36Z |
Staged surgery for advanced cardiac intimal sarcoma involving the right atrium and the inferior vena cava
|
Chen Y.-A.; Li Y.; JEN-CHIEH LEE; Chen J.-W. |
| 臺大學術典藏 |
2022-02-14T07:10:36Z |
Molecular Characterization of Dermatofibrosarcoma Protuberans The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions
|
Lee P.-H.; Huang S.-C.; Wu P.-S.; Tai H.-C.; Lee C.-H.; JEN-CHIEH LEE; Kao Y.-C.; Tsai J.-W.; Hsieh T.-H.; Li C.-F.; Li W.-S.; Liu T.-T.; Su Y.-L.; Yu S.-C.; Huang H.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:37Z |
Integrated screens identify CDK1 as a therapeutic target in advanced gastrointestinal stromal tumors
|
Lu X.; Pang Y.; Cao H.; Liu X.; Tu L.; Shen Y.; Jia X.; JEN-CHIEH LEE; Wang Y. |
| 臺大學術典藏 |
2022-02-14T07:10:37Z |
Clinicopathological and molecular characterisation of USP6-rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone-forming capacity
|
Wang J.-C.; Li W.-S.; Kao Y.-C.; JEN-CHIEH LEE; Lee P.-H.; Huang S.-C.; Tsai J.-W.; Chen C.-C.; Chang C.-D.; Yu S.-C.; Huang H.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:37Z |
An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1-rearranged uterine sarcoma with variable sex-cord differentiation
|
Kao Y.-C.; JEN-CHIEH LEE |
| 臺大學術典藏 |
2022-02-14T07:10:37Z |
Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors
|
JEN-CHIEH LEE; Li W.-S.; Kao Y.-C.; Chung Y.-C.; Huang H.-Y. |
| 臺大學術典藏 |
2022-02-14T07:10:38Z |
OGT-rearranged Acral Mesenchymal Neoplasms: An Emerging Entity with an Expanding Pathologic and Molecular Spectrum
|
JEN-CHIEH LEE; Hsieh T.-H.; Kao Y.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:38Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin C.-Y.; Huang K.-Y.; Lin Y.-C.; Yang S.-C.; Chung W.-C.; YIH-LEONG CHANG; Shih J.-Y.; Ho C.-C.; Lin C.-A.; Shih C.-C.; Chang Y.-H.; Kao S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-14T07:10:38Z |
Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis
|
Liang C.-W.; Yang C.-Y.; Flavin R.; Fletcher J.A.; Lu T.-P.; Lai I.-R.; Li Y.-I.; Chang Y.-L.; JEN-CHIEH LEE |
